Reporting Period: October 2011 - September 2012

	Compared to other Joint Commission Accredited Organizations
Measure Area	Nationwide	Statewide
Children's Asthma Care Read More Close Children's Asthma Care This category of evidenced based measures assesses the use of indicated treatment for children's asthma in hospitalized children age 2 through 17 years.

	Compared to other Joint Commission Accredited Organizations
	Nationwide			Statewide
Measure	Hospital Results	Top 10% Scored at Least:	Average Rate:	Top 10% Scored at Least:	Average Rate:
Use of Relievers for Inpatient Asthma Overall Rate. Age 2-17 Read More Close Use of Relievers for Inpatient Asthma Overall Rate. Age 2-17 This measure reports the overall number of pediatric asthma patients age 2 through 17 years who received relievers during hospitalization. An asthma reliever is a drug that provides relief from asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	100% of 444 eligible Patients7
Use of Systemic Corticosteroids for Inpatient Asthma Overall Rate. Age 2-17 Read More Close Use of Systemic Corticosteroids for Inpatient Asthma Overall Rate. Age 2-17 This measure reports the overall number of pediatric asthma patients age 2 through 17 years who received systemic corticosteroids during hospitalization. A systemic corticosteroid is a medication used to reduce airway inflammation and control moderate to severe asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	99% of 444 eligible Patients7
Children's Asthma Care Age 2-4 Read More Close Children's Asthma Care Age 2-4 Overall report on use of indicated treatment for children's asthma in hospitalized children age 2 through 4 years. Indicated treatment for children's asthma includes relievers and systemic corticosteroids. (See Quarterly Results)		100%	100%	100%	100%
	99% of 392 eligible Patients7
Use of relievers for inpatient asthma. Age 2-4 Read More Close Use of relievers for inpatient asthma. Age 2-4 This measure reports the number of pediatric asthma patients age 2 through 4 years who received relievers during hospitalization. An asthma reliever is a drug that provides relief from asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	100% of 196 eligible Patients7
Use of systemic corticosteroids for inpatient asthma. Age 2-4 Read More Close Use of systemic corticosteroids for inpatient asthma. Age 2-4 This measure reports the number of pediatric asthma patients age 2 through 4 years who received systemic corticosteroids during hospitalization. A systemic corticosteroid is a medication used to reduce airway inflammation and control moderate to severe asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	98% of 196 eligible Patients7
Children's Asthma Care Age 5-12 Read More Close Children's Asthma Care Age 5-12 Overall report on use of indicated treatment for children's asthma in hospitalized children age 5 through 12 years. Indicated treatment for children's asthma includes relievers and systemic corticosteroids. (See Quarterly Results)		100%	100%	100%	100%
	99% of 406 eligible Patients7
Use of relievers for inpatient asthma. Age 5-12 Read More Close Use of relievers for inpatient asthma. Age 5-12 This measure reports the number of pediatric asthma patients age 5 through 12 years who received relievers during hospitalization. An asthma reliever is a drug that provides relief from asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	100% of 203 eligible Patients7
Use of systemic corticosteroids for inpatient asthma. Age 5-12 Read More Close Use of systemic corticosteroids for inpatient asthma. Age 5-12 This measure reports the number of pediatric asthma patients age 5 through 12 years who received systemic corticosteroids during hospitalization. A systemic corticosteroid is a medication used to reduce airway inflammation and control moderate to severe asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	99% of 203 eligible Patients7
Children's Asthma Care Age 13-17 Read More Close Children's Asthma Care Age 13-17 Overall report on use of indicated treatment for children's asthma in hospitalized children age 13 through 17 years. Indicated treatment for children's asthma includes relievers and systemic corticosteroids. (See Quarterly Results)		100%	100%	100%	100%
	100% of 90 eligible Patients7
Use of relievers for inpatient asthma. Age 13-17 Read More Close Use of relievers for inpatient asthma. Age 13-17 This measure reports the number of pediatric asthma patients age 13 through 17 years who received relievers during hospitalization. Note: an asthma reliever is a drug that provides relief from asthma symptoms. (See Quarterly Results)		100%	100%	100%	100%
	100% of 45 eligible Patients7
Use of systemic corticosteroids for inpatient asthma. Age 13-17 Read More Close Use of systemic corticosteroids for inpatient asthma. Age 13-17 This measure reports the number of pediatric asthma patients age 13 through 17 years who received systemic corticosteroids during hospitalization. A systemic corticosteroid is a medication used to reduce airway inflammation and control moderate to severe asthma symptoms. (See Quarterly Results)		100%	100%	100%	99%
	100% of 45 eligible Patients7
Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver Read More Close Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver This measure reports the number of pediatric asthma patients and/or their caregivers who were given a written Home Management Plan of Care document (HMPC). The HMPC addresses all of the following: 1.) Arrangements for follow-up care; 2.) How to avoid those things that cause an asthma attack; 3.) What to do if asthma symptoms worsen after discharge; 4.) How and when to use controller medications; 5.) How and when to use reliever medications. (See Quarterly Results)		99%	86%	98%	89%
	87% of 442 eligible Patients7
The Joint Commission only reports measures endorsed by the National Quality Forum.   * This information is part of the Hospital Quality Alliance. This information can also be viewed at www.hospitalcompare.hhs.gov. ---- Null value or data not displayed. 1 - The measure or measure set was not reported. 2 - The measure set does not have an overall result. 3 - The number is not enough for comparison purposes. 4 - The measure meets the Privacy Disclosure Threshold rule. 5 - The organization scored above 90% but was below most other organizations. 6 - The measure results are not statistically valid. 7 - The measure results are based on a sample of patients. 8 - The number of months with measure data is below the reporting requirement. 9 - The measure results are temporarily suppressed. 10 - Test Measure: a measure being evaluated for reliability of the individual data elements or awaiting National Quality Forum Endorsement. 11 - There were no eligible patients that met the denominator criteria.